Integrated Diagnostics HoldingsLSE:IDHC 59 Days Inventory is 30.59 as of Mar. 2026, which is 3% above its 10-year median of 29.79. GuruFocus rates LSE:IDHC with a GF Score™ of 59/100 and a GF Value™ of $0.59 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Integrated Diagnostics Holdings ranks worse than 66.67% on this metric.
The historical rank and industry rank for Integrated Diagnostics Holdings's Days Inventory or its related term are showing as below:
LSE:IDHC'
s Days Inventory Range Over the Past 10 Years
Min: 24.34 Med: 29.79 Max: 104.2
Current: 104.2
During the past 13 years, Integrated Diagnostics Holdings's highest Days Inventory was 104.20. The lowest was 24.34. And the median was 29.79.
LSE:IDHC's Days Inventory is ranked worse than 66.67% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 70.8
vs LSE:IDHC: 104.20
Inventory Turnover measures how fast the company turns over its inventory within a year.
Integrated Diagnostics Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.98.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integrated Diagnostics Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.20.
Integrated Diagnostics Holdings (LSE:IDHC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Integrated Diagnostics Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integrated Diagnostics Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Integrated Diagnostics Holdings Days Inventory Related Terms
Integrated Diagnostics Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Diagnostics Holdings Days Inventory Chart
LSE:IDHC vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Diagnostics Holdings Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Integrated Diagnostics Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Diagnostics Holdings (LSE:IDHC) has a Days Inventory of 30.59 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integrated Diagnostics Holdings and its competitors. This is near median its historical median of 29.79. Over the past decade, Integrated Diagnostics Holdings' Days Inventory has ranged from 24.34 to 104.20. According to the industry distribution chart, Integrated Diagnostics Holdings ranks #118 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 66.7%.
Is Integrated Diagnostics Holdings' Days Inventory too high?
Integrated Diagnostics Holdings' current Days Inventory of 30.59 is near median its 10-year median of 29.79. Over the past 10 years, this metric has ranged from a low of 24.34 to a high of 104.20. The Medical Diagnostics & Research industry median Days Inventory is 70.80. Integrated Diagnostics Holdings' value of 30.59 is 56.8% below this industry median. Based on the distribution chart, Integrated Diagnostics Holdings ranks #118 out of 177 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Integrated Diagnostics Holdings has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integrated Diagnostics Holdings' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integrated Diagnostics Holdings ranks #118 out of 177 companies for Days Inventory. This places Integrated Diagnostics Holdings in the lower half of its industry. The industry median Days Inventory is 70.80. Integrated Diagnostics Holdings' value of 30.59 is 56.8% below this benchmark. Historically, Integrated Diagnostics Holdings' own Days Inventory has ranged from 24.34 to 104.20 over the past decade. While the company's 10-year median is 29.79 vs. the industry median of 70.80, Integrated Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 70.80, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Diagnostics Holdings's current Days Inventory of 30.59 is 56.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integrated Diagnostics Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 70.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Diagnostics Holdings's current Days Inventory is 30.59, which is near median its own 10-year median of 29.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings (LSE:IDHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.59, compared to a current price of $0.50 — trading 14.9% below its estimated fair value. The current Days Inventory is 30.59, which is near median its 10-year median of 29.79 and 56.8% below the Medical Diagnostics & Research industry median of 70.80. Integrated Diagnostics Holdings' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Integrated Diagnostics Holdings (LSE:IDHC), the current Days Inventory is 30.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued.
The current stock price of $0.50 is trading 14.9% below its estimated GF Value™ of $0.59.
GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.
Key valuation signals for LSE:IDHC:
Days Inventory: 30.59 (near median its 10-year median of 29.79)
GF Value™: $0.59 vs. price of $0.50 (14.9% below fair value)
Industry Position: 56.8% below the Medical Diagnostics & Research median (#118 of 177)
No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Diagnostics Holdings Business Description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
59GF Score
Get the complete analysis for LSE:IDHC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IDHC has been successfully added to your 
